RT Journal Article
SR Electronic
T1 Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.2023-0625
DO 10.3899/jrheum.2023-0625
A1 Hazlewood, Glen S.
A1 Akhavan, Pooneh
A1 Pardo Pardo, Jordi
A1 Agarwal, Arnav
A1 Schieir, Orit
A1 Barber, Claire E.H.
A1 Proulx, Laurie
A1 Richards, Dawn P.
A1 Bombardier, Claire
A1 Pope, Janet E.
A1 Barnabe, Cheryl
A1 Tugwell, Peter
A1 Jamal, Shahin
A1 Thorne, J. Carter
A1 Nikolic, Roko P.A.
A1 Khraishi, Majed
A1 Bansback, Nick
A1 Legge, Alexandra
A1 Bykerk, Vivian
A1 Taylor-Gjevre, Regina
YR 2023
UL http://www.jrheum.org/content/early/2023/07/25/jrheum.2023-0625.abstract
AB We have updated the Canadian Rheumatology Association (CRA) guidelines for rheumatoid arthritis, with a series of best practice statements and a recommendation for the choice of disease-modifying antirheumatic drug therapy after an inadequate response to tumor necrosis factor inhibitors (TNFi). These add to our prior recommendation for tapering of advanced therapy.1